L-thyroxine pseudomalabsorption: a factitious disease;Pseudomalabsorption de L-thyroxine : une forme de pathomimie

Presse Medicale

Volumn 36, Issue 10 I, 2007, Pages 1390-1394

  Molines, Laurent ^a   Fromont, Isabelle ^a   Morlet Barla, Nathalie ^a   Nogueira, Juan Patricio ^a   Valéro, René ^a   Vialettes, Bernard ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROID HORMONE; THYROXINE;

AGED; ARTICLE; CASE REPORT; FACTITIOUS DISEASE; FEMALE; HOSPITALIZATION; HUMAN; HYPOTHYROIDISM; LEVO THYROXINE PSEUDOMALABSORPTION; MALABSORPTION; PATIENT COMPLIANCE; THYROID FUNCTION TEST; THYROIDECTOMY; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; INTESTINE ABSORPTION; METABOLISM; NODULAR GOITER; TIME;

AGED; DIAGNOSIS, DIFFERENTIAL; FACTITIOUS DISORDERS; FEMALE; GOITER, NODULAR; HUMANS; HYPOTHYROIDISM; INTESTINAL ABSORPTION; MALABSORPTION SYNDROMES; PATIENT COMPLIANCE; THYROIDECTOMY; THYROXINE; TIME FACTORS;

EID: 34548849774     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2006.09.024     Document Type: Article

References (39)

1. Toft A.D. Thyroxin therapy. N Engl J Med 331 (1994) 174-180
2. Lips D.J., Van Reisen M.T., Voigt V., and Venekamp W. Diagnosis and treatment of levothyroxine pseudomalabsorption. Neth J Med 62 (2004) 114-118
3. Stoffer S.S., and Szpunar W.E. Potency of brand name and generic levothyroxine. JAMA 244 (1980) 1704-1705
4. Grussendorf M., Vaupel R., and Wegscheider K. Bioequivalence of L-thyroxine tablets and a liquid L-thyroxine solution in the treatment of hypothyroid patients. Med Klin 99 (2004) 639-644
5. Peran S., Garriga M.J., Morreale de Escobar G., Asuncion M., and Peran M. Increase in plasma thyrotropin levels in hypothyroid patients during treatment due to a defect in, commercial preparation. J Clin Endocrinol Metab 82 (1997) 3192-3195
6. Sawin C.T., Surks M.I., London M., Ranganathan C., and Larsen P.R. Oral thyroxine: variation in biologic action and tablet content. Ann Intern Med 100 (1984) 641-645
7. Yamamoto T. Tablet formulation of levothyroxine is absorbed less well than powdered levothyroxin. Thyroid 13 (2003) 1177-1181
8. Rossi D., Simonin G., Carayon P., and Codaccioni J.L. Traitement substitutif de l'hypothyroïdie par la Dl-thyroxine. Les comprimés ne valent pas les gouttes. Presse Med 13 (1984) 679-680
9. Vaisman M., Spina L.D., Eksterman L.F., dos Santos M.J., Lima J.S., Volpato N.M., et al. Comparative bioavailability of two oral L-thyroxine formulations after multiple dose administration in patients with hypothyroidism and its relation with therapeutic endpoints and dissolution profiles. Arzneimittelforschung 51 (2001) 246-252
10. Jauk B., Mikosch P., Gallowitsch H.J., Kresnik E., Molnar M., Gomez I., et al. Unusual malabsorption of levothyroxine. Thyroid 10 (2000) 93-95
11. Grebe S.K., Cooke R.R., Ford H.C., Fagerstrom J.N., Cordwell D.P., Lever N.A., et al. Treatment of hypothyroidism with once weekly thyroxine. J Clin Endocrinol Metab 82 (1997) 870-875
12. McDermott J.H., Coss A., and Walsh C.H. Celiac disease presenting as resistant hypothyroidism. Thyroid 15 (2005) 386-388
13. Bevan J.S., and Munro J.F. Thyroxin malabsorption following intestinal bypass surgery. Int J Obes 10 (1986) 245-246
14. Smyrniotis V., Vaos N., Arkadopoulos N., Kopstopannagiotou G., Theodoraki K., and Lambrou A. Severe hypothyroidism in patients dependent on prolonged thyroxine infusion through a jejunostomy. Clin Nutr 19 (2000) 65-67
15. Rosenberg R. Malabsorption of thyroid hormone with cholestyramine administration. Conn Med 58 (1994) 109
16. Mersebach H., Rasmussen A.K., Kirkegarrd L., and Feldt-Rasmussen U. Intestinal adsorption of levothyroxine by antiacids and laxatives: case stories and in vitro experiments. Pharmacol Toxicol 84 (1999) 107-109
17. Jonderko G., Jonderko K., Marcisz C., and Kotulska A. Effect of cimetidine and ranitidine on absorption of [125I]levothyroxine administered orally. Zhongguo Yao Li Xue Bao. 13 (1992) 391-394
18. Bergman F., Halvorsen P., and van der Linden W. Increased excretion of thyroxin by feeding activated charcoal to Syrians hamsters. Acta Endocrinol (Copenh) 56 (1967) 521-524
19. Singh N., Wesler S.L., and Hershman J.M. The acute effect of calcium carbonate on the intestinal absorption of levothyroxine. Thyroid 11 (2001) 967-971
20. Leger C.S., and Ooi T.C. Ferrous fumarate-induced malabsorption of thyroxin. Endocrinologist (1999) 493-495
21. Van der Heijden J.T., Krenning E.P., van Toor H., Hennemann G., and Docter R. Three compartmental analyss of effects of D-propanolol on thyroid hormons kinetics. Am J Physiol 255 (1988) E80-E86
22. Demke D.M. Drug interaction between thyroxine and lovastatin. N Engl J Med 321 (1989) 1341-1342
23. Kisch E., and Segall H.S. Interaction between simvastatin and L-thyroxine. Ann Intern Med 143 (2005) 547
24. Fdigge J., and Dluhy R.G. Amiodarone-induced elevation of thyroid stimulating hormone in patients receiving levothyroxine for primary hypothyroidism. Ann Intern Med 113 (1990) 553-555
25. Mishell Jr. D.R., Colodny S.Z., and Swanson L.A. The effects of an oral contraceptive on tests of thyroid function. Fertil Steril 20 (1969) 335-339
26. Siraj E.S., Gupta M.K., and Reddy S.S. Raloxifène causing malabsorption of levothyroxine. Ann Intern Med 163 (2003) 1367-1370
27. Nolan S.R., Self T.H., and Norwood J.M. Interaction between Rifampin and levothyroxine. South Med J 92 (1999) 529-531
28. Gaskill C.L., Burton S.A., Gelens H.C., Ihle S.L., Miller J.B., Shaw D.H., et al. Changes in serum thyroxin and thyroid-stimulating hormone concentrations in epileptic dogs receiving phenobarbital for one year. J Vet Pharmacol Ther 23 (2000) 43-49
29. Schroder van der Elst J.P., and van der Heide D. Effects of 5,5'-diphenylhydantoin on thyroxine and 3,5,3'triodothyronin concentrations in several tissues of the rat. Endocrinology 126 (1990) 186-191
30. De luca F., Arrigo T., Pandullo E., Siracusano M.F., Benvenga S., and Trimarchi F. Changes in thyroid function tests induced 2 month carbamazepine treatment in L-thyroxin substituted hypothyroid children. Eur J Pediatr 145 (1986) 77-79
31. De Groot J.W., Zonnenberg B.A., Plukker J.T., van der Graaf W.T., and Links T.P. Imatinib induces hypothyroidism in patients receiving levothyroxine. Clin Pharmacol Ther 78 (2005) 433-438
32. McCowen K.C., Garber J.R., and Spark R. Elevated serum thyrotropine in thyroxine-treated patients with hypothyroidism given sertraline. N Engl J Med 337 (1997) 1010-1011
33. Conrad S.C., Chiu H., and Silverman B.F. Soy formula complicates management of congenital hypothyroidism. Arch Dis Child 89 (2004) 1077
34. Choe W., and Hays M.T. Absorption of oral thyroxine. Endocrinologist 5 (1995) 222-228
35. Geatti O., Barkan A., Turrin D., Orsolon P.G., and Shapiro B. L-thyroxine malabsorption due to the injection of herbal remedies. Thyroidology 5 (1993) 97-102
36. Chopra I.J., and Baber K. Treatment of primary hypothyroidism during pregnancy: is there an increase in thyroxine dose requirement in pregnancy?. Metabolism 52 (2003) 122-128
37. Danzi S., and Klein I. Thyroid hormone and the cardiovascular system. Minerva Endocrinol 29 (2004) 139-150
38. Junglee N.A., Scanlon M.F., and Rees D.A. Increasing thyroxine requirements in primary hypothyroidism: Don't forget the urinalysis. J Postgrad Med 52 (2006) 201-203
39. Centanni M., Gargano L., Canettieri G., Viceconti N., Franchi A., Delle Fave G., et al. Thyroxine in goiter, Helicobacter pylori infection and chronic gastritis. N Engl J Med 17 (2006) 1787-1795